Sri Lanka’s rupee closed at 301.58/70 to the US dollar Thursday, in the spot market Thursday down from 301.40/50 to the dollar, a day earlier while bond yields were flat.

Sri Lanka's coconut exporters have warned that a 30 percent Trump tariff will hit 20 percent of annual exports as competitors, have got access at much lower rates to the United States.

Australia’s Market Development Facility (MDF) and Sri Lanka’s Department of Export Agriculture (DEA) have signed a deal to develop Sri Lanka’s specialty coffee industry, says Global Coffee Report. The ...

President Trump is pushing through with his tariff agenda, unveiling a new batch of letters to country leaders outlining ...

The bill, sponsored by Senator Cameron Reny of Bristol, aims to strengthen the Maine Prescription Drug Affordability Board and reduce prescription drug costs.

The lawsuit’s targets are pharmacy benefit managers (PBMs). PBMs are the little-known heroes of the American healthcare system. They act as intermediaries to negotiate drug prices with Big Pharma on ...

CVS Caremark has been ordered to pay $95 million after a federal judge found the pharmacy benefit manager improperly inflated Medicare Part D drug prices by failing to report required pharmacy ...

Sri Lanka plans to discuss strategies with the International Monetary Fund (IMF) to lure foreign investment, President Anura Kumara Dissanayake said on Monday, in the aftermath of the Indian Ocean ...

Sri Lanka’s isolation during past glacial cycles resulted in the evolution of unique species, but ongoing human-induced climate change now poses a major threat to their survival.

Feds schedule 'listening sessions' to combat high drug prices and boost competition One question is how well the agencies will listen to employers and benefits advisors.

Republicans historically have opposed using so-called most-favored nation policy to lower drug prices, but that appears to be changing as President Trump backs the approach.

The bipartisan Biosimilar Red Tape Elimination Act would cut drug prices and increase competition in the pharmaceutical market by categorizing generic brand "biosimilar" drugs as interchangeable ...